These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37862797)

  • 1. Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
    He WZ; Huang YH; Hu WM; Wang F; Xu YX; Yi JH; Xue J; Yang YZ; Chao XY; Lin HB; Guo GF; Yun JP; Xia LP
    Eur J Cancer; 2023 Nov; 194():113337. PubMed ID: 37862797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
    Huang YH; Zhang CZ; Huang QS; Yeong J; Wang F; Yang X; He YF; Zhang XL; Zhang H; Chen SL; Zheng YL; Deng R; Lin CS; Yang MM; Li Y; Jiang C; Kin-Wah Lee T; Ma S; Zeng MS; Yun JP
    J Hepatol; 2021 Apr; 74(4):838-849. PubMed ID: 33212090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-1 blockade and radiotherapy combination for advanced Epstein-Barr virus-associated intrahepatic cholangiocarcinoma: a case report and literature review.
    Liao CX; Deng CS; Liang X; Yang JC; Chen ZZ; Lin XY; Lin CF; Chen S; Wu SS
    Front Immunol; 2023; 14():1239168. PubMed ID: 37753076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma.
    Chiang NJ; Hou YC; Tan KT; Tsai HW; Lin YJ; Yeh YC; Chen LT; Hou YF; Chen MH; Shan YS
    Hepatol Int; 2022 Oct; 16(5):1137-1149. PubMed ID: 35780451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection.
    Zheng L; Zhou N; Yang X; Wei Y; Yi C; Gou H
    Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102244. PubMed ID: 37944749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-associated intrahepatic cholangiocarcinoma bearing an intense lymphoplasmacytic infiltration.
    Xiao P; Shi H; Zhang H; Meng F; Peng J; Ke Z; Wang K; Liu Y; Han A
    J Clin Pathol; 2012 Jun; 65(6):570-3. PubMed ID: 22267965
    [No Abstract]   [Full Text] [Related]  

  • 7. Lenvatinib Plus Programmed Cell Death Protein-1 Inhibitor Beyond First-Line Systemic Therapy in Refractory Advanced Biliary Tract Cancer: A Real-World Retrospective Study in China.
    Shi C; Li Y; Yang C; Qiao L; Tang L; Zheng Y; Chen X; Qian Y; Yang J; Wu D; Xie F
    Front Immunol; 2022; 13():946861. PubMed ID: 35967452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of Epstein-Barr virus (EBV) in intrahepatic cholangiocarcinoma confirmed by lack of EBV-coded nuclear RNA and latent membrane protein-1.
    Ozaki S; Harada K; Watanabe K; Furubo S; Tsui WM; Nakanuma Y
    Histopathology; 2000 Jan; 36(1):50-3. PubMed ID: 10632752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy.
    Deng M; Li S; Wang Q; Zhao R; Zou J; Lin W; Mei J; Wei W; Guo R
    Ann Med; 2022 Dec; 54(1):803-811. PubMed ID: 35272564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic roles of leptin-signaling proteins, PD-L1, and tumor-infiltrating lymphocytes in surgically-resected biliary tract cancers.
    Byeon SJ; Chang MS; Cho HJ; Park JH; Kim KH; Park JH; Choi IS; Kim W; Han DS; Ahn HS; Heo SC
    J Surg Oncol; 2023 Mar; 127(4):587-597. PubMed ID: 36367404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein
    Peng L; Peng X; Duan S; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):319-330. PubMed ID: 38755729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epstein-Barr virus associated lymphoepithelioma-like cholangiocarcinoma: a clinicopathological analysis of three cases].
    Du MZ; Guo LC; Huang S; Guo X; Zhu BY
    Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):841-843. PubMed ID: 37527991
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphoepithelioma-like cholangiocarcinoma: an Epstein-Barr virus-associated tumor.
    Jeng YM; Chen CL; Hsu HC
    Am J Surg Pathol; 2001 Apr; 25(4):516-20. PubMed ID: 11257627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoepithelioma-like cholangiocarcinoma (LELC) not associated with Epstein-Barr virus.
    Szekely E
    Am J Surg Pathol; 2001 Nov; 25(11):1464-6. PubMed ID: 11684969
    [No Abstract]   [Full Text] [Related]  

  • 15. Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma.
    Wang L; Dong H; Ni S; Huang D; Tan C; Chang B; Sheng W
    Oncotarget; 2016 Oct; 7(43):69749-69759. PubMed ID: 27626174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Plasma Epstein-Barr Virus DNA With Outcomes for Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Receiving Anti-Programmed Cell Death 1 Immunotherapy.
    Xu JY; Wei XL; Ren C; Zhang Y; Hu YF; Li JY; Chen JL; Wang YQ; Han F; Wang FH
    JAMA Netw Open; 2022 Mar; 5(3):e220587. PubMed ID: 35230439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
    Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
    Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.
    Larbcharoensub N; Mahaprom K; Jiarpinitnun C; Trachu N; Tubthong N; Pattaranutaporn P; Sirachainan E; Ngamphaiboon N
    Am J Clin Oncol; 2018 Dec; 41(12):1204-1210. PubMed ID: 29672367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype.
    Cho CJ; Kang HJ; Ryu YM; Park YS; Jeong HJ; Park YM; Lim H; Lee JH; Song HJ; Jung HY; Kim SY; Myung SJ
    Gastric Cancer; 2018 Nov; 21(6):925-935. PubMed ID: 29627937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infection-associated cholangiocarcinoma: a report of one case and the review of literature.
    Zhang X; Wang N; Wei W; Li Y
    Virol J; 2022 Aug; 19(1):133. PubMed ID: 35945590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.